Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNA-seq of human RUES2 and iPSC derived CMs at day 15 of differentiation

ABSTRACT: The definition of lncRNAs conservation remain a crucial challenge. In order to identify more promising relevant cardiac ncRNAs, we selected transcripts also present in human cardiac cells. We performed total RNA-seq in human RUES2 and iPSC derived cardiomyocyte at day 15 of differentiation, first for human transcripts identification and secondly for the orthologous selection.

ORGANISM(S): Homo sapiens

PROVIDER: GSE143930 | GEO | 2020/09/07

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNA-seq of human RUES2 and iPSC derived CMs at day 15 of differentiation

Project description:RNA-seq of human RUES2 and iPSC derived CMs at day 15 of differentiation

| PRJNA602226 | ENA

4DNESNTQV8XL - Replicate experiments of RNA-seq on RUES2

Project description:4DNESNTQV8XL - Replicate experiments of RNA-seq on RUES2

| PRJNA919042 | ENA

Functional dissection of human cardiac enhancers with hiPSC-CMs and lentiMPRA

Project description:To assess human cardiac enhancer activity, 400 bp candidate cardiac enhancers and controls were tested in iPSC-CMs using lentiMPRA.

2023-11-16 | GSE211417 | GEO

4DNES8R5RDVD - Replicate experiments of DNase Hi-C on RUES2 with DNaseI

Project description:4DNES8R5RDVD - Replicate experiments of DNase Hi-C on RUES2 with DNaseI

| PRJNA919044 | ENA

4DNESXR4J4MS - Replicate experiments of RNA-seq on RUES2 differentiated to mesoderm

Project description:4DNESXR4J4MS - Replicate experiments of RNA-seq on RUES2 differentiated to mesoderm

| PRJNA919046 | ENA

RNA-seq in healthy and SQT1 hiPSC-CMs upon manipulation of miR-365

Project description:Abnormalities of ventricular action potential (AP) cause malignant cardiac arrhythmias and sudden cardiac death. Here, we sought to identify microRNAs (miRNAs) that regulate the human cardiac AP and asked whether their manipulation allows for therapeutic modulation of AP abnormalities. Quantitative analysis of the miRNA targetomes in human cardiac myocytes identified miR-365 as a primary miRNA to regulate repolarizing ion channels. AP recordings in patient-specific induced pluripotent stem cell-derived cardiac myocytes (iPSC-CMs) showed that elevation of miR-365 level significantly prolonged AP duration in hiPSC-CMs derived from a Short-QT syndrome (SQTS) patient, whereas specific inhibition of miR-365 normalized pathologically prolonged AP in Long-QT syndrome (LQTS) iPSC-CMs. Transcriptome analyses in human iPSC-CMs at bulk and single-cell level corroborated the key cardiac repolarizing channels as direct targets of miR-365, together with functionally synergistic regulation of additional AP-regulating genes by this miRNA. Whole-cell patch clamp experiments revealed miR-365-based regulation of repolarizing ionic currents. Finally, refractory period measurements in human myocardial slices substantiated the prolonging effect of miR-365 on AP duration also in adult human myocardial tissue. Our results delineate miR-365 to regulate human cardiac AP duration by targeting key factors of cardiac repolarization.

2021-12-01 | GSE185687 | GEO

single cell RNA-seq in healthy and LQT1 hiPSC-CMs upon manipulation of miR-365

2021-12-01 | GSE185688 | GEO

4DNESLQDCU1A - Replicate experiments of RNA-seq on RUES2 differentiated to endothelial cell

Project description:4DNESLQDCU1A - Replicate experiments of RNA-seq on RUES2 differentiated to endothelial cell

| PRJNA919043 | ENA

Effect of lincRNA-p21 knockdown on neonatal mouse cardiomyocytes (CMs) treated with phenylephrine (PE)

Project description:Cardiac hypertrophy is an adaptive response to pressure overload aimed at maintaining cardiac function. However, prolonged hypertrophy significantly increases the risk of maladaptive cardiac remodeling and heart failure. The role of cardiac long non-coding RNAs in cardiac hypertrophy and cardiomyopathy is not well understood. lincRNA-p21 was induced in mouse and human cardiomyopathy tissue. Global and cardiac-specific lincRNA-p21 knockout significantly suppressed pressure overload-induced ventricular wall thickening, stress marker elevation, and deterioration of cardiac function. Genome-wide transcriptome analysis and transcriptional network analysis revealed that lincRNA-p21 acts in trans to stimulate the NFAT/MEF2 pathway. Mechanistically, lincRNA-p21 bound to the scaffold protein KAP1. lincRNA-p21 cardiac-specific knockout suppressed stress-induced nuclear accumulation of KAP1, and KAP1 knockdown attenuated cardiac hypertrophy and NFAT activation. KAP1 positively regulated pathological hypertrophy by physically interacting with NFATC4 to promote the overactive status of NFAT/MEF2 signaling. Importantly, GapmeR ASO depletion of lincRNA-p21 similarly inhibited cardiac hypertrophy and adverse remodeling, highlighting the therapeutic potential of inhibiting lincRNA-p21.

2024-06-11 | GSE262892 | GEO

4DNESVIKXE89 - Replicate experiments of RNA-seq on RUES2 differentiated to endothelial progenitor cell

Project description:4DNESVIKXE89 - Replicate experiments of RNA-seq on RUES2 differentiated to endothelial progenitor cell

| PRJNA919048 | ENA